Variant report

Variant	nsv527328
Chromosome Location	chr6:26372786-26379537
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:42)
CpG islands
(count:62)
Chromatin interactive
region (count:14)
LncRNA
region (count:4)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:42 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:26372942-26373010	K562	blood:	n/a	n/a
2	BATF	chr6:26378427-26378675	GM12878	blood:	n/a	n/a
3	BHLHE40	chr6:26372951-26372953	K562	blood:	n/a	n/a
4	CTCF	chr6:26375220-26375370	RPTEC	kidney:	n/a	n/a
5	CTCF	chr6:26373360-26373510	GM12872	blood:	n/a	n/a
6	CTCF	chr6:26375238-26375287	HepG2	liver:	n/a	n/a
7	CTCF	chr6:26375208-26375320	MCF-7	breast:	n/a	n/a
8	CTCF	chr6:26375241-26375290	Fibrobl	skin:	n/a	n/a
9	CUX1	chr6:26372864-26373028	K562	blood:	n/a	n/a
10	CUX1	chr6:26376629-26376662	GM12878	blood:	n/a	n/a
11	EP300	chr6:26372773-26372967	K562	blood:	n/a	n/a
12	EP300	chr6:26372800-26373043	K562	blood:	n/a	n/a
13	GATA1	chr6:26372546-26373289	PBDE	blood:	n/a	chr6:26372919-26372929 chr6:26372961-26372968 chr6:26372954-26372975 chr6:26372961-26372968 chr6:26372957-26372973 chr6:26372961-26372968 chr6:26372958-26372968
14	HMGN3	chr6:26373010-26373233	K562	blood:	n/a	n/a
15	JUND	chr6:26373013-26373045	K562	blood:	n/a	n/a
16	MAFF	chr6:26378477-26378591	K562	blood:	n/a	n/a
17	MAFF	chr6:26378400-26378648	HepG2	liver:	n/a	n/a
18	MAFK	chr6:26378394-26378674	HepG2	liver:	n/a	chr6:26378530-26378545
19	MAFK	chr6:26378397-26378674	IMR90	lung:	n/a	chr6:26378530-26378545
20	MAFK	chr6:26378410-26378666	HepG2	liver:	n/a	chr6:26378530-26378545
21	MAFK	chr6:26378461-26378567	K562	blood:	n/a	chr6:26378530-26378545
22	MAZ	chr6:26372911-26373083	K562	blood:	n/a	n/a
23	MAZ	chr6:26374541-26374597	HepG2	liver:	n/a	n/a
24	POLR2A	chr6:26379220-26379340	HepG2	liver:	n/a	n/a
25	POLR2A	chr6:26376973-26377022	HepG2	liver:	n/a	n/a
26	POLR2A	chr6:26377645-26377700	HepG2	liver:	n/a	n/a
27	POLR2A	chr6:26378290-26378472	HepG2	liver:	n/a	n/a
28	POLR2A	chr6:26378860-26378991	HepG2	liver:	n/a	n/a
29	POLR2A	chr6:26377390-26377448	HepG2	liver:	n/a	n/a
30	POLR2A	chr6:26375423-26376057	PFSK-1	brain:	n/a	n/a
31	POLR2A	chr6:26376851-26376954	HepG2	liver:	n/a	n/a
32	POLR2A	chr6:26378519-26378561	HepG2	liver:	n/a	n/a
33	RCOR1	chr6:26372588-26373275	K562	blood:	n/a	n/a
34	REST	chr6:26375555-26375832	PFSK-1	brain:	n/a	n/a
35	SPI1	chr6:26376502-26376739	GM12891	blood:	n/a	chr6:26376607-26376616
36	SPI1	chr6:26376475-26376762	GM12878	blood:	n/a	chr6:26376607-26376616
37	SPI1	chr6:26376460-26376761	GM12891	blood:	n/a	chr6:26376607-26376616
38	TAL1	chr6:26372809-26373044	K562	blood:	n/a	n/a
39	TBL1XR1	chr6:26372796-26373048	K562	blood:	n/a	n/a
40	USF1	chr6:26372494-26372801	K562	blood:	n/a	n/a
41	ZNF384	chr6:26372771-26372971	K562	blood:	n/a	n/a
42	ZNF384	chr6:26373449-26373456	K562	blood:	n/a	n/a

(count:62 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:26375990-26376040	AoSMC	blood vessel:	n/a
2	chr6:26375990-26376040	AoSMC	blood vessel:	n/a
3	chr6:26375990-26376040	K562	blood:	n/a
4	chr6:26375990-26376040	Hepatocyte	liver:	n/a
5	chr6:26375990-26376040	HMEC	breast:	n/a
6	chr6:26375990-26376040	AG04449	skin:	fetal
7	chr6:26375990-26376040	AG04450	lung:	fetal
8	chr6:26375990-26376040	GM19239	blood:	n/a
9	chr6:26375990-26376040	CMK	blood:	n/a
10	chr6:26375990-26376040	HPAEpiC	pulmonary alveolar:	n/a
11	chr6:26375990-26376040	Caco-2	colon:	n/a
12	chr6:26375990-26376040	NB4	blood:	n/a
13	chr6:26375990-26376040	HL-60	blood:	n/a
14	chr6:26375990-26376040	NH-A	brain:	n/a
15	chr6:26375990-26376040	PFSK-1	brain:	n/a
16	chr6:26375990-26376040	SAEC	small airway:	n/a
17	chr6:26375990-26376040	HEEpiC	esophagus:	n/a
18	chr6:26375990-26376040	T-47D	breast:	n/a
19	chr6:26375990-26376040	HRCEpiC	kidney:	n/a
20	chr6:26375990-26376040	HRE	kidney:	n/a
21	chr6:26375990-26376040	HUVEC	blood vessel:	n/a
22	chr6:26375990-26376040	ovcar-3	ovarian:	n/a
23	chr6:26375990-26376040	HIPEpiC	eye:	n/a
24	chr6:26375990-26376040	AG10803	skin:	n/a
25	chr6:26375990-26376040	Hela-S3	cervix:	n/a
26	chr6:26375990-26376040	MCF-7	breast:	n/a
27	chr6:26375990-26376040	U87	brain:	n/a
28	chr6:26375990-26376040	HEK293	kidney:	embryo
29	chr6:26375990-26376040	GM12891	blood:	n/a
30	chr6:26375990-26376040	SKMC	muscle:	n/a
31	chr6:26375990-26376040	HCT-116	colon:	n/a
32	chr6:26375990-26376040	HepG2	liver:	n/a
33	chr6:26375990-26376040	AG09309	skin:	n/a
34	chr6:26375990-26376040	ProgFib	skin:	n/a
35	chr6:26375990-26376040	IMR90	lung:	fetal
36	chr6:26375990-26376040	GM12878	blood:	n/a
37	chr6:26375990-26376040	AG09319	gingival:	n/a
38	chr6:26375990-26376040	HCM	heart:	n/a
39	chr6:26375990-26376040	ECC-1	luminal epithelium:	n/a
40	chr6:26375990-26376040	BE2_C	brain:	n/a
41	chr6:26375990-26376040	A549	lung:	n/a
42	chr6:26375990-26376040	HNPCEpiC	eye:	n/a
43	chr6:26375990-26376040	SK-N-SH_RA	brain:	n/a
44	chr6:26375990-26376040	LNCaP	prostate:	n/a
45	chr6:26375990-26376040	GM06990	blood:	n/a
46	chr6:26375990-26376040	H1-hESC	embryonic stem cell:	embryo
47	chr6:26375990-26376040	NHBE	bronchial:	n/a
48	chr6:26375990-26376040	BJ	skin:	n/a
49	chr6:26375990-26376040	GM12892	blood:	n/a
50	chr6:26375990-26376040	PrEC	prostate:	n/a

(count:14 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:26376258..26380187-chr6:26381333..26383262,3	K562	blood:
2	chr6:26374643..26376462-chr6:26381050..26382858,2	K562	blood:
3	chr6:26373307..26375855-chr6:26376435..26379484,4	K562	blood:
4	chr6:26378930..26384775-chr6:26385231..26390850,8	MCF-7	breast:
5	chr6:26360109..26361715-chr6:26372989..26375105,2	K562	blood:
6	chr6:26378690..26380275-chr6:26532676..26534577,2	K562	blood:
7	chr6:26214943..26217251-chr6:26374280..26376179,2	K562	blood:
8	chr6:26350980..26353776-chr6:26378882..26380453,2	K562	blood:
9	chr6:26373111..26374832-chr6:26379026..26381530,2	MCF-7	breast:
10	chr6:26370389..26373294-chr6:26375542..26378035,2	K562	blood:
11	chr6:26373111..26374832-chr6:26379026..26381530,2	MCF-7	breast:
12	chr6:26370389..26374393-chr6:26375542..26380304,5	K562	blood:
13	chr6:26373194..26374949-chr6:26387423..26389905,2	K562	blood:
14	chr6:26373307..26375855-chr6:26376435..26379484,4	K562	blood:

(count:4 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-BTN2A2-2	chr6:26373504-26373641	NONHSAT108273
2	lnc-BTN2A2-2	chr6:26374999-26375036	NONHSAT108273
3	lnc-BTN2A2-2	chr6:26372921-26375929	NONHSAT108275
4	lnc-BTN2A2-2	chr6:26374555-26374601	NONHSAT108273

No data

Variant related genes	Relation type
BTN3A2	TF binding region
BTN2A2	TF binding region
BTN3A2	CpG island
BTN2A2	CpG island
ENSG00000124508	chromatin interactions
ENSG00000168274	chromatin interactions
ENSG00000186470	chromatin interactions
ENSG00000187990	chromatin interactions
ENSG00000252399	chromatin interactions

Extended variants
information (count: 349 )
Associated
traits (count: 103 )

Variant overlapped rSNPs/rCNVs (count:349 , 50 per page) page: 1 2 3 4 5 6 7

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs12176317	chr6:26372786-26372787	Weak transcription Strong transcription Genic enhancers Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs12174602	chr6:26372827-26372828	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
3	rs577196376	chr6:26372829-26372830	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs183244006	chr6:26372886-26372887	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs560173089	chr6:26372977-26372978	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
6	rs562507742	chr6:26373072-26373073	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
7	rs371481033	chr6:26373076-26373077	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
8	rs12174623	chr6:26373086-26373087	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
9	rs541871717	chr6:26373087-26373088	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
10	rs560756333	chr6:26373109-26373110	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
11	rs371708538	chr6:26373116-26373117	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
12	rs529887353	chr6:26373120-26373121	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
13	rs12174639	chr6:26373121-26373122	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
14	rs566739896	chr6:26373127-26373128	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
15	rs142279595	chr6:26373128-26373129	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
16	rs532046699	chr6:26373133-26373134	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
17	rs368782404	chr6:26373141-26373142	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
18	rs372417646	chr6:26373143-26373144	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
19	rs12174631	chr6:26373150-26373151	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
20	rs568843545	chr6:26373157-26373158	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
21	rs139423944	chr6:26373190-26373191	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
22	rs144393024	chr6:26373201-26373202	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
23	rs568607568	chr6:26373215-26373216	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
24	rs534380775	chr6:26373248-26373249	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
25	rs531941877	chr6:26373302-26373303	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
26	rs146618645	chr6:26373307-26373308	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
27	rs111392726	chr6:26373308-26373309	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
28	rs554201845	chr6:26373310-26373311	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
29	rs200135502	chr6:26373326-26373327	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
30	rs369533018	chr6:26373334-26373335	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
31	rs375000542	chr6:26373343-26373344	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
32	rs369322724	chr6:26373363-26373364	Weak transcription Strong transcription Genic enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
33	rs13202216	chr6:26373425-26373426	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
34	rs145639750	chr6:26373434-26373435	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
35	rs72500811	chr6:26373446-26373447	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
36	rs151188818	chr6:26373462-26373463	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
37	rs575986690	chr6:26373465-26373466	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
38	rs375373091	chr6:26373489-26373490	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
39	rs368309824	chr6:26373490-26373491	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
40	rs371734919	chr6:26373491-26373492	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
41	rs12208235	chr6:26373493-26373494	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
42	rs374882814	chr6:26373494-26373495	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
43	rs377114514	chr6:26373495-26373496	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
44	rs13216828	chr6:26373507-26373508	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
45	rs373033223	chr6:26373535-26373536	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
46	rs375536490	chr6:26373541-26373542	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
47	rs201407881	chr6:26373551-26373552	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
48	rs199592212	chr6:26373570-26373571	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
49	rs529878369	chr6:26373641-26373642	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
50	rs144016445	chr6:26373642-26373643	Weak transcription Strong transcription Genic enhancers Enhancers	lncRNA	n/a	Overlapped CNVs	n/a

Variant related diseases (count:103)

Disease	PMID	Source
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Lung cancer	18438408	CNVD
Multiple myeloma	17550852	CNVD
Ewing''s sarcoma	17952124	CNVD
Gastric cancer	16891809	CNVD
Ovarian cancer	21781307	CNVD
Autism	21448237	CNVD
Cancer	20164919	CNVD
Melanoma	18172304	CNVD
Breast cancer	22844521	CNVD
HIV/AIDS	22844521	CNVD
Ovarian cancer	22844521	CNVD
Prostate cancer	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
Breast cancer	22522925	CNVD
Breast cancer	21552322	CNVD
Immune disease	21076436	CNVD
Autoimmune disease	19135723	CNVD
Systemic lupus erythematosus	17953491	CNVD
Recurrent Infections	22737222	CNVD
Systemic lupus erythematosus	21904924	CNVD
Ependymoma	19289631	CNVD
Gestational infection	22844521	CNVD
Head circumference	22844521	CNVD
Infertility	22844521	CNVD
Recurrent birth weight diabetes	22844521	CNVD
Obesity	22844521	CNVD
Recurrent pregnancy loss	22844521	CNVD
Intellectual disability	21811512	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Nasopharyngeal cancer	22815911	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	21115979	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	17133270	CNVD
Autism	22495311	CNVD
Burkitt''s lymphoma	19759907	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Cancer	16790693	CNVD
Breast cancer	22032731	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	21785460	CNVD
Retinoblastoma	16790693	CNVD
Esophageal adenocarcinoma	18820669	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
T-cell lymphomas	19863542	CNVD
Urothelial carcinoma	18382360	CNVD
Breast cancer	21364760	CNVD
Cancer	21183584	CNVD
small cell lung cancer	20016488	CNVD
Williams-beuren syndrome	16971481	CNVD
Renal cell carcinoma	18765545	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Autism	22495309	CNVD
Lung cancer	21569311	CNVD
Breast cancer	21509527	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD

Chromatin state (count:258 , 50 per page) page: 1 2 3 4 5 6

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:26365800-26375200	Weak transcription	Aorta	Aorta
2	chr6:26366000-26373200	Weak transcription	Colonic Mucosa	Colon
3	chr6:26366000-26373800	Weak transcription	Brain Inferior Temporal Lobe	brain
4	chr6:26366000-26374800	Weak transcription	Esophagus	oesophagus
5	chr6:26366000-26375000	Weak transcription	Brain Anterior Caudate	brain
6	chr6:26366000-26375600	Weak transcription	Gastric	stomach
7	chr6:26366000-26382600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
8	chr6:26366000-26383000	Weak transcription	Brain Hippocampus Middle	brain
9	chr6:26366000-26383200	Weak transcription	H9 Cell Line	embryonic stem cell
10	chr6:26366000-26383200	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
11	chr6:26366000-26383200	Weak transcription	Pancreas	Pancrea
12	chr6:26366000-26383200	Weak transcription	Skeletal Muscle Male	skeletal muscle
13	chr6:26366000-26383200	Weak transcription	HSMMtube	muscle
14	chr6:26366000-26383400	Weak transcription	Placenta Amnion	Placenta Amnion
15	chr6:26366200-26374600	Weak transcription	Muscle Satellite Cultured Cells	--
16	chr6:26366200-26374800	Weak transcription	Stomach Smooth Muscle	stomach
17	chr6:26366200-26375000	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
18	chr6:26366200-26375200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
19	chr6:26366200-26375800	Weak transcription	NH-A	brain
20	chr6:26366200-26382400	Weak transcription	Cortex derived primary cultured neurospheres	brain
21	chr6:26366200-26383200	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
22	chr6:26366200-26383200	Weak transcription	Pancreatic Islets	Pancreatic Islet
23	chr6:26367000-26374400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
24	chr6:26367000-26377800	Weak transcription	Foreskin Fibroblast Primary Cells skin01	Skin
25	chr6:26367000-26383000	Weak transcription	NHEK	skin
26	chr6:26367000-26383200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
27	chr6:26367200-26374600	Weak transcription	NHLF	lung
28	chr6:26367400-26375000	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
29	chr6:26367600-26372800	Weak transcription	NHDF-Ad	bronchial
30	chr6:26367600-26373400	Genic enhancers	Primary T cells fromperipheralblood	blood
31	chr6:26367600-26374600	Weak transcription	Hela-S3	cervix
32	chr6:26367800-26373000	Weak transcription	GM12878-XiMat	blood
33	chr6:26367800-26378600	Weak transcription	Small Intestine	intestine
34	chr6:26368800-26375200	Strong transcription	Primary B cells from cord blood	blood
35	chr6:26368800-26376000	Genic enhancers	Primary T helper cells fromperipheralblood	blood
36	chr6:26369200-26374800	Strong transcription	Fetal Adrenal Gland	Adrenal Gland
37	chr6:26369400-26373600	Genic enhancers	Primary T killer naive cells fromperipheralblood	blood
38	chr6:26369400-26375200	Strong transcription	Fetal Lung	lung
39	chr6:26369400-26377000	Strong transcription	Fetal Muscle Leg	muscle
40	chr6:26369400-26377600	Strong transcription	Primary hematopoietic stem cells	blood
41	chr6:26369400-26378000	Strong transcription	Liver	Liver
42	chr6:26369400-26378200	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
43	chr6:26369800-26378200	Strong transcription	Thymus	Thymus
44	chr6:26369800-26383000	Weak transcription	Skeletal Muscle Female	skeletal muscle
45	chr6:26370200-26373000	Genic enhancers	Primary T helper naive cells from peripheral blood	blood
46	chr6:26370200-26374000	Weak transcription	Osteobl	bone
47	chr6:26370200-26375200	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
48	chr6:26370200-26375200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
49	chr6:26370200-26377800	Strong transcription	Primary hematopoietic stem cells short term culture	blood
50	chr6:26370400-26373000	Weak transcription	Left Ventricle	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links